Pharmaceuticals

Growth In The Montelukast Sodium Market Is Being Driven By Rising Osteoporosis Prevalence Sparks Surge In Bone And Joint Health Supplements

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Montelukast Sodium Market Grow Between 2026 And 2030?

The montelukast sodium market has experienced robust growth in recent years. It is forecast to increase from $4.2 billion in 2025 to $4.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. This historical growth can be ascribed to the extensive clinical application of montelukast in managing asthma, the rising occurrence of allergic respiratory conditions, its well-established safety profile for prolonged treatment, widespread endorsement by physicians for maintenance therapy, and the presence of affordable generic alternatives.

The montelukast sodium market is projected for significant expansion over the coming years. By 2030, its valuation is anticipated to reach $6.33 billion, demonstrating a compound annual growth rate (CAGR) of 8.4%. This projected growth is driven by several factors, including the increasing worldwide prevalence of asthma and allergic rhinitis, a rise in pediatric asthma diagnoses, heightened understanding of non-steroidal asthma treatments, wider availability of respiratory medications in developing regions, and sustained need for oral maintenance medications. Key trends anticipated during this period involve an escalating demand for leukotriene receptor antagonists for asthma management, the expanding application of montelukast in treating allergic rhinitis, the proliferation of generic montelukast sodium formulations, a leaning towards oral solid dosage forms in chronic respiratory therapy, and a surge in prescriptions for both pediatric and adult asthma sufferers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What Factors Are Contributing To The Growth Of The Montelukast Sodium Market?

The rising incidence of asthma is projected to boost the expansion of the montelukast sodium market in the coming years. Asthma is a long-term respiratory condition characterized by inflammation and narrowing of the airways, leading to recurring episodes of wheezing, shortness of breath, chest tightness, and coughing. The growing occurrence of asthma can be attributed to factors such as environmental contamination, exposure to allergens, genetic predispositions, urban development, evolving lifestyles, and respiratory illnesses. Montelukast sodium, a leukotriene receptor antagonist, is utilized in asthma to prevent and manage symptoms by blocking the activity of leukotrienes, which are responsible for airway inflammation and constriction. For example, in October 2024, data from the National Asthma Council, an Australia-based non-profit organization, indicated that Australia registered a total of 474 asthma-related deaths in 2023, with 325 females and 149 males. This figure closely mirrors the 473 asthma-related deaths reported in 2022, pointing to a stable pattern in asthma mortality over this two-year period. Consequently, the increasing prevalence of asthma is a primary driver for the growth of the montelukast sodium market.

What Are The Key Segment Divisions In The Montelukast Sodium Market Segment Structure?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

What Trends Are Influencing The Montelukast Sodium Market?

Leading firms within the montelukast sodium market are prioritizing the creation of novel solutions, notably combination therapies, aiming to offer more extensive relief for allergies and asthma and enhance patient compliance. These therapies involve administering two or more medications concurrently in a singular treatment plan to address various disease mechanisms, thereby boosting effectiveness. An illustrative case occurred in October 2025, when Cadila Pharmaceuticals Ltd., an India-based pharmaceutical firm, introduced its Dlorfast-M tablets. This product is a fixed-dose combination treatment composed of desloratadine (5 mg) and montelukast (10 mg), intended for managing allergic rhinitis and urticaria. It offers wide-ranging symptom management by acting upon both histamine and leukotriene pathways through an accessible once-daily oral administration. The primary goals of this inventive formulation are to enhance patient adherence and provide sustained relief while maintaining favorable tolerability.

Which Organizations Are Engaged In The Montelukast Sodium Market?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Get The Full Montelukast Sodium Market Report:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Region Leads The Montelukast Sodium Market In Terms Of Market Share?

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Montelukast Sodium Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Browse Through More Reports Similar to the Global Montelukast Sodium Market 2026, By The Business Research Company

Montelukast Sodium Market Report 2026

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Sodium Reduction Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

Sodium Benzoate Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-benzoate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795